Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-25-012591

CHIEF OPERATING OFFICER sold 6,667 shares at an average $18.39 ($122,579)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-07 Sale : show line 1 in the form 10b5-1 −6,173 $18.30 $112,947 310,470 I
2025-05-07 Sale : show line 2 in the form 10b5-1 −390 $19.40 $7,565 310,080 I
2025-05-07 Sale : show line 3 in the form 10b5-1 −104 $19.87 $2,067 309,976 I
Open-market sales · 6,667 sh · avg $18.39 · $122,579
Loading xslF345X05/form4-05092025_100535.xml…